Safety Handling: This material is a technical-grade chemical intended for industrial production and laboratory research use only
Customer Service and Contact Info For any questions about orders, dosage guidance, or product information, customers can reach Healthletic via: Email : [email protected] Website Chat : Available during standard business hours FAQs : A helpful knowledge base is provided on their site Still dealing with joint, gut, or tissue strain
It has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease
Product Attributes Scientific References DSIP Delta sleep-inducing peptide (DSIP): a review Observational | Animal | In vitro Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients Human RCT | Observational The delta sleep-inducing peptide (DSIP): a still unresolved riddle Animal | In vitro DSIP in the treatment of chronic insomnia: a double-blind clinical trial Human RCT Influence of DSIP on the secretion of pituitary hormones in humans Observational | Human RCT Delta sleep-inducing peptide modulates the stress response in rats Animal Delta sleep-inducing peptide: structure, function and clinical perspectives Observational | Animal | In vitro Antioxidant properties of delta sleep-inducing peptide in experimental models Animal | In vitro Selank Anxiolytic activity of the heptapeptide Selank in clinical trials Human RCT | Observational Effects of Selank on the expression of genes encoding inflammatory factors and BDNF Animal | In vitro Selank enhances the expression of BDNF and the trkB receptor in the hippocampus Animal Comparative study of the anxiolytic effects of Selank and medazepam in patients with generalized anxiety disorder Human RCT Effect of Selank on monoamine neurotransmitter metabolism in the brain of rats Animal Selank and its analogs modulate GABAergic transmission in experimental anxiety models Animal | In vitro Peptide Selank as a candidate for the correction of cognitive deficits Animal Immunomodulatory and anxiolytic properties of the synthetic peptide Selank Observational | Animal Epithalon Peptide promotes overcoming of the division limit in human somatic cell In vitro Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells In vitro Inhibition of development of spontaneous mammary tumors in mice by Epithalon Animal Effect of Epithalon on biomarkers of aging, life span and spontaneous tumor incidence in female rats Animal Pineal peptide preparation Epithalamin and tetrapeptide Epitalon: results of clinical use in humans Observational Peptides and aging: relevance to cancer prevention and longevity research Animal | In vitro Epithalon and aging: experimental and clinical perspectives Observational | Animal Telomerase activation and senescence pathways in peptide research In vitro Pinealon Short peptides stimulate cell regeneration in skin during aging Animal | In vitro Peptide regulation of cell differentiation Animal | In vitro Epigenetic aspects of peptidergic regulation of vascular endothelial cell proliferation during aging Animal | In vitro Tripeptides restore the number of neuronal spines under conditions of in vitro modeled Alzheimers disease In vitro Pinealon enhances resistance of cells of cerebral cortex of rat embryos to oxidative stress Animal | In vitro Peptidergic regulation of cell proliferation and renewal during aging Observational | Animal Neuroprotective effects of peptide bioregulators in experimental models of neurodegeneration Animal | In vitro Glutathione Randomized controlled trial of oral glutathione supplementation on body stores of glutathione Human RCT Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function Human RCT Glutathione synthesis in the mouse liver supports lipid abundance through NRF2 repression Animal Glutathione system enhancement for cardiac protection: pharmacological and clinical data from bench-to-bedside Observational Randomized clinical trial of how long-term glutathione supplementation improves lipid metabolism in obese patients with nonalcoholic fatty liver disease Human RCT ALSUntangled no
Both medicines remain in active clinical development, with phase 2 and phase 3 trials ongoing
The naturally occurring protective protein sequence originates from gastric tissue, while laboratory BPC-157 is chemically synthesised
